Trial Profile
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Mar 2013
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms REALITY
- Sponsors AstraZeneca
- 27 Mar 2013 Treatment table added.
- 21 Jan 2011 Actual end date changed from Aug 2006 to Sep 2006 as reported by ClinicalTrials.gov record.
- 30 Dec 2008 New trial record.